Literature DB >> 9343187

Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift.

R Khanna1, R W Slade, L Poulsen, D J Moss, S R Burrows, J Nicholls, J M Burrows.   

Abstract

The question whether immune pressure exerted by cytotoxic T lymphocytes (CTLs) can influence the long-term evolution of genetically stable viruses such as Epstein-Barr virus (EBV) has generated considerable scientific interest, primarily due to its important implications for the overall biology of the virus. While arguing for a role of CTLs in the evolution of viruses, it is important to differentiate between genetic variation in virus and immune recognition of these variant virus by CTLs. To assess the role of genetic selection in the long-term evolution of EBV, we have analyzed a large panel of type 1 EBV isolates from African, Southeast Asian, Papua-New Guinean (PNG), and Australian Caucasian individuals. Seven different regions of the EBV genome, which include nine CTL epitopes restricted through a range of HLA class I alleles, were sequenced and compared. Although numerous nucleotide changes were identified within these isolates, comparison of synonymous and nonsynonymous substitutions in the CTL epitope indicated that the genetic variation was generated mostly independently of immune selection pressure. Surprisingly, an inverse correlation between genetic variation within certain CTL epitopes and the frequency distribution of HLA alleles that present the CTL epitopes was seen, suggesting that the evolutionary pressures on the CTL epitopes of the virus may be toward their conservation rather than their inactivation. Furthermore, molecular evolutionary genetic analysis of nucleotide sequences revealed that viral isolates from PNG are evolving as a lineage distinct from isolates from African, Southeast Asian, and Australian Caucasian individuals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343187      PMCID: PMC192293     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  REAP: an integrated environment for the manipulation and phylogenic analysis of restriction data.

Authors:  D McElroy; P Moran; E Bermingham; I Kornfield
Journal:  J Hered       Date:  1992 Mar-Apr       Impact factor: 2.645

2.  Estimation of levels of gene flow from DNA sequence data.

Authors:  R R Hudson; M Slatkin; W P Maddison
Journal:  Genetics       Date:  1992-10       Impact factor: 4.562

3.  Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo.

Authors:  H Pircher; D Moskophidis; U Rohrer; K Bürki; H Hengartner; R M Zinkernagel
Journal:  Nature       Date:  1990-08-16       Impact factor: 49.962

4.  Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.

Authors:  R E Phillips; S Rowland-Jones; D F Nixon; F M Gotch; J P Edwards; A O Ogunlesi; J G Elvin; J A Rothbard; C R Bangham; C R Rizza
Journal:  Nature       Date:  1991-12-12       Impact factor: 49.962

5.  The neighbor-joining method: a new method for reconstructing phylogenetic trees.

Authors:  N Saitou; M Nei
Journal:  Mol Biol Evol       Date:  1987-07       Impact factor: 16.240

6.  Statistical tests of neutrality of mutations.

Authors:  Y X Fu; W H Li
Journal:  Genetics       Date:  1993-03       Impact factor: 4.562

7.  Presentation of endogenous viral peptide epitopes by anti-CD40 stimulated human B cells following recombinant vaccinia infection.

Authors:  R Khanna; C A Jacob; S R Burrows; D J Moss
Journal:  J Immunol Methods       Date:  1993-08-26       Impact factor: 2.303

8.  HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population.

Authors:  P O de Campos-Lima; R Gavioli; Q J Zhang; L E Wallace; R Dolcetti; M Rowe; A B Rickinson; M G Masucci
Journal:  Science       Date:  1993-04-02       Impact factor: 47.728

9.  Biological activity of recombinant human interleukin-2 produced in Escherichia coli.

Authors:  S A Rosenberg; E A Grimm; M McGrogan; M Doyle; E Kawasaki; K Koths; D F Mark
Journal:  Science       Date:  1984-03-30       Impact factor: 47.728

10.  Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.

Authors:  R Khanna; S R Burrows; M G Kurilla; C A Jacob; I S Misko; T B Sculley; E Kieff; D J Moss
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

View more
  24 in total

1.  EBNA-1 sequences in endemic and sporadic Burkitt's lymphoma.

Authors:  K Bhatia; I Magrath
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

Review 2.  The immunology of Epstein-Barr virus infection.

Authors:  D J Moss; S R Burrows; S L Silins; I Misko; R Khanna
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

3.  Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes.

Authors:  R S Midgley; A I Bell; D J McGeoch; A B Rickinson
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

4.  Selection pressure-driven evolution of the Epstein-Barr virus-encoded oncogene LMP1 in virus isolates from Southeast Asia.

Authors:  Jacqueline M Burrows; Lindell Bromham; Megan Woolfit; Gwenaël Piganeau; Judy Tellam; Geoff Connolly; Natasha Webb; Leith Poulsen; Leanne Cooper; Scott R Burrows; Denis J Moss; Sofia M Haryana; Mun Ng; John M Nicholls; Rajiv Khanna
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

5.  Specific mutation of a gammaherpesvirus-expressed antigen in response to CD8 T cell selection in vivo.

Authors:  Joy Loh; Daniel L Popkin; Lindsay Droit; Douglas C Braaten; Guoyan Zhao; Xin Zhang; Punit Vachharajani; Nancy Myers; Ted H Hansen; Herbert W Virgin
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

Review 6.  Molecular evolution of the gamma-Herpesvirinae.

Authors:  D J McGeoch
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

7.  Cytotoxic T-lymphocyte responses to a polymorphic Epstein-Barr virus epitope identify healthy carriers with coresident viral strains.

Authors:  J M Brooks; D S Croom-Carter; A M Leese; R J Tierney; G Habeshaw; A B Rickinson
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

8.  Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.

Authors:  Manuel Albanese; Takanobu Tagawa; Mickaël Bouvet; Liridona Maliqi; Dominik Lutter; Jonathan Hoser; Maximilian Hastreiter; Mitch Hayes; Bill Sugden; Larissa Martin; Andreas Moosmann; Wolfgang Hammerschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

9.  HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences.

Authors:  R S Midgley; A I Bell; Q Y Yao; D Croom-Carter; A D Hislop; B M Whitney; A T C Chan; P J Johnson; A B Rickinson
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  Epstein-barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas.

Authors:  G Habeshaw; Q Y Yao; A I Bell; D Morton; A B Rickinson
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.